| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $62.6M | — | -2.0% |
| Cost of Revenue | $26.1M | — | +2.0% |
| Gross Profit | $36.5M | — | -4.6% |
| R&D Expense | $8.0M | — | -9.0% |
| SG&A Expense | $14.8M | — | +1.6% |
| Operating Income | -$15.3M | — | -28.3% |
| Pre-tax Income | -$15.1M | — | -33.4% |
| Income Tax | -$2.6M | — | -41.5% |
| Net Income | -$12.5M | — | -31.9% |
| EPS (Basic) | -$0.27 | — | -35.0% |
| EPS (Diluted) | -$0.27 | — | -35.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $144.9M | -0.4% | +42.3% |
| Accounts Receivable | $336.9M | -6.0% | -3.5% |
| Current Assets | $504.2M | -3.5% | -0.2% |
| Total Assets | $659.4M | -3.1% | -1.4% |
| Current Liabilities | $368.9M | -1.9% | +5.3% |
| Total Liabilities | $408.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $17.3M | — | +10.7% |
| Capital Expenditures | $11K | — | -99.2% |
| Investing Cash Flow | -$9.6M | — | +4.8% |
| Financing Cash Flow | -$8.1M | — | -80.2% |
| Free Cash Flow | $17.3M | — | +21.9% |
| +3.9% |
| Stockholders' Equity | $251.0M | -4.4% | -8.9% |